0000899243-22-024971.txt : 20220705
0000899243-22-024971.hdr.sgml : 20220705
20220705160539
ACCESSION NUMBER: 0000899243-22-024971
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220705
DATE AS OF CHANGE: 20220705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: West Linda
CENTRAL INDEX KEY: 0001805257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 221064829
MAIL ADDRESS:
STREET 1: C/O GALERA THERAPEUTICS, INC.
STREET 2: 2 W LIBERTY BLVD., #110
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-01
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001805257
West Linda
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
1
0
0
0
Stock Option (Right to Buy)
1.29
2022-07-01
4
A
0
58496
0.00
A
2032-06-30
Common Stock
58496
58496
D
This option was awarded pursuant to the "elective option" provisions of the Issuer's non-employee director compensation program for the Reporting Peron's service on the Issuer's Board and certain of its
committees. This option shall vest and become exercisable as to 25% of the shares subject to the option upon the Reporting Person completing each three months of continuous service as a Non-Employee Director, or in the applicable committee position, following the date of grant, provided that the fourth and final tranche of the option will vest and become exercisable on the earlier of July 1, 2023 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director, or in the applicable committee position, through such vesting date.
/s/ Christopher Degnan, Attorney-in-Fact for Linda West
2022-07-05